151 related articles for article (PubMed ID: 28780084)
1. Nuclear maspin expression: A biomarker for budding assessment in colorectal cancer specimens.
Banias L; Gurzu S; Kovacs Z; Bara T; Bara T; Jung I
Pathol Res Pract; 2017 Sep; 213(9):1227-1230. PubMed ID: 28780084
[TBL] [Abstract][Full Text] [Related]
2. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
3. Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer.
Märkl B; Arnholdt HM; Jähnig H; Schenkirsch G; Herrmann RA; Haude K; Spatz H; Anthuber M; Schlimok G; Oruzio D
Hum Pathol; 2010 Jul; 41(7):1024-33. PubMed ID: 20334895
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition.
Banias L; Jung I; Bara T; Fulop Z; Simu P; Simu I; Satala C; Gurzu S
Oncol Lett; 2020 Feb; 19(2):1487-1495. PubMed ID: 31966075
[TBL] [Abstract][Full Text] [Related]
5. Maspin and Nm23-H1 expression in colorectal cancer.
Pasz-Walczak G; Salagacka A; Potemski P; Balcerczak E; Kordek R; Mirowski M
Neoplasma; 2010; 57(2):95-101. PubMed ID: 20099971
[TBL] [Abstract][Full Text] [Related]
6. Expression of maspin in colorectal cancer.
Umekita Y; Souda M; Yoshida H
In Vivo; 2006; 20(6B):797-800. PubMed ID: 17203770
[TBL] [Abstract][Full Text] [Related]
7. Practical value of the new system for Maspin assessment, in colorectal cancer.
Gurzu S; Szentirmay Z; Popa D; Jung I
Neoplasma; 2013; 60(4):373-83. PubMed ID: 23581409
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
9. The Role of Galectin3, Tubulinβ, and Maspin in Promoting Tumor Budding in Colorectal Carcinoma and Their Clinical Implications.
Elkady N; Allam DM
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):143-150. PubMed ID: 38251657
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
11. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
[TBL] [Abstract][Full Text] [Related]
12. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer.
Dietmaier W; Bettstetter M; Wild PJ; Woenckhaus M; Rümmele P; Hartmann A; Dechant S; Blaszyk H; Pauer A; Klinkhammer-Schalke M; Hofstädter F
Int J Cancer; 2006 May; 118(9):2247-54. PubMed ID: 16331619
[TBL] [Abstract][Full Text] [Related]
15. Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.
Frey A; Soubani AO; Adam AK; Sheng S; Pass HI; Lonardo F
Histopathology; 2009 Apr; 54(5):590-7. PubMed ID: 19309490
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node-positive colonic cancer.
Fung CL; Chan C; Jankova L; Dent OF; Robertson G; Molloy M; Bokey L; Chapuis PH; Lin BP; Clarke SJ
Histopathology; 2010 Feb; 56(3):319-30. PubMed ID: 20459532
[TBL] [Abstract][Full Text] [Related]
17. Possible predictive value of maspin expression in colorectal cancer.
Gurzu S; Szentirmay Z; Toth E; Jung I
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):183-90. PubMed ID: 22963136
[TBL] [Abstract][Full Text] [Related]
18. Expression of Snail transcription factor in prostatic adenocarcinoma in Egypt: correlation with Maspin protein expression and clinicopathologic variables.
Fawzy AI; Gayyed MF; Elsaghir GA; Elbadry MS
Int J Clin Exp Pathol; 2013; 6(8):1558-66. PubMed ID: 23923074
[TBL] [Abstract][Full Text] [Related]
19. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
Boltze C
Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
[TBL] [Abstract][Full Text] [Related]
20. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
